Axon Enterprise, Inc $AXON Position Lifted by MUFG Securities EMEA plc

MUFG Securities EMEA plc raised its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 115.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,235 shares of the biotechnology company’s stock after acquiring an additional 1,732 shares during the quarter. MUFG Securities EMEA plc’s holdings in Axon Enterprise were worth $1,837,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV bought a new position in Axon Enterprise during the 4th quarter valued at $28,000. New Millennium Group LLC bought a new position in Axon Enterprise during the 3rd quarter valued at $29,000. Sound Income Strategies LLC boosted its stake in Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 44 shares during the last quarter. Camelot Portfolios LLC bought a new position in Axon Enterprise during the 4th quarter valued at $30,000. Finally, Lodestone Wealth Management LLC bought a new position in Axon Enterprise during the 4th quarter valued at $35,000. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Erika Nardini sold 198 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total transaction of $100,302.84. Following the transaction, the director owned 1,946 shares of the company’s stock, valued at approximately $985,804.68. This trade represents a 9.24% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jeri Williams sold 157 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the transaction, the director directly owned 1,159 shares in the company, valued at approximately $567,910. The trade was a 11.93% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 2,355 shares of company stock valued at $977,233. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Trading Up 6.3%

Shares of NASDAQ:AXON opened at $476.88 on Tuesday. The company has a market cap of $38.44 billion, a PE ratio of 191.52, a P/E/G ratio of 8.16 and a beta of 1.44. The company’s 50-day moving average price is $407.02 and its 200 day moving average price is $493.35. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.60 by $0.01. The firm had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. Axon Enterprise’s quarterly revenue was up 33.7% on a year-over-year basis. During the same quarter last year, the company earned $1.47 EPS. Sell-side analysts anticipate that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on AXON. Zacks Research upgraded shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 19th. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Weiss Ratings upgraded shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. Barclays reduced their price target on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research report on Friday, May 8th. Finally, William Blair restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $712.75.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.